Clinuvel Pharmaceuticals (CUV): Looking to Vitiligo
Reviewing vitiligo expectations, Phase 3 readout CY25CUV are conducting two Phase 3 trials to expand the label of Scenesse to include patients with...
Seven Group Holdings (SVW): Rounding out the portfolio
With the Boral (BLD) acquisition nearing completion, we revisit our SVW model forecasts, updating our attributable SVW financials, BLD valuation...
No more insights